Christos Hatzis has a Ph.D in Chemical Engineering from the University of Minnesota and a BS in Chemical Engineering from the University of Patras. Christos has held various leadership positions at companies such as HiFiBiO Therapeutics, Bristol Myers Squibb, Nuvera Biosciences, and Silico Insights. Additionally, Christos has served as an Adjunct Associate Professor Of Medicine at Yale University School of Medicine and has held various teaching positions there. Throughout their career, Christos has focused on translational medicine, clinical pharmacogenomics, bioinformatics, and personalized medicine in cancer.
Current role